EUVIMEDEUVIMED entdecken
Crossref

Design of pyrrolo[2,3- d ]pyrimidine-endoperoxide hybrids as first-in-class dual degraders of cyclin D1/3 and CDK4/6 with potent antiproliferative effects

Zhen Cui, Yuanli Yang, Changqi Wang, Jiayi Zhu, Haowei Jiao, Lu Wang, Silong Zhang iD, Huan He iD, Hang Zhong iD

Organic & Biomolecular Chemistry · 2025

DOI: 10.1039/d5ob00501a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic & Biomolecular Chemistry, 2025. Verfasst von Zhen Cui und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences/Guizhou Engineering Laboratory for Synthetic Drugs, Guizhou University, Guiyang, China. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Pyrimidines, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hyperactive Cyclin D-CDK4/6 heterodimer is a key cell cycle regulator in breast cancer, and CDK4/6 inhibitors featuring pyridine/pyrrolo[2,3- d ]pyrimidine scaffolds are clinically used treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6PyrimidinesAntineoplastic AgentsDrug DesignPyrrolesProtein Kinase InhibitorsCyclin D1Cyclin D3HumansCell ProliferationDrug Screening Assays, AntitumorStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugCell Line, Tumor

Substanzen

Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6PyrimidinesAntineoplastic AgentsPyrrolesProtein Kinase InhibitorsCyclin D1CDK4 protein, humanCyclin D3Pyrrolo(2,3-d)pyrimidine

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences/Guizhou Engineering Laboratory for Synthetic Drugs, Guizhou University, Guiyang, China.
  • Chemical Engineering Center, Guizhou University, Guiyang, China.
  • Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, Zunyi Medical University, Zunyi, China.

ORCID-Profile: Silong Zhang, Huan He, Hang Zhong

Förderung

  • National Natural Science Foundation of China
  • Guizhou University

Zitieren

APA

Cui, Z., Yang, Y., Wang, C., Zhu, J., Jiao, H., Wang, L., Zhang, S., He, H., & Zhong, H. (2025). Design of pyrrolo[2,3- d ]pyrimidine-endoperoxide hybrids as first-in-class dual degraders of cyclin D1/3 and CDK4/6 with potent antiproliferative effects. Organic & Biomolecular Chemistry. https://doi.org/10.1039/d5ob00501a

Vancouver

Cui Z, Yang Y, Wang C, Zhu J, Jiao H, Wang L, et al. Design of pyrrolo[2,3- d ]pyrimidine-endoperoxide hybrids as first-in-class dual degraders of cyclin D1/3 and CDK4/6 with potent antiproliferative effects. Organic & Biomolecular Chemistry. 2025. doi:10.1039/d5ob00501a

BibTeX
@article{Cui2025,
  author = {Cui, Zhen and Yang, Yuanli and Wang, Changqi and Zhu, Jiayi and Jiao, Haowei and Wang, Lu and Zhang, Silong and He, Huan and Zhong, Hang},
  title = {Design of pyrrolo[2,3- d ]pyrimidine-endoperoxide hybrids as first-in-class dual degraders of cyclin D1/3 and CDK4/6 with potent antiproliferative effects},
  journal = {Organic & Biomolecular Chemistry},
  year = {2025},
  doi = {10.1039/d5ob00501a}
}
Kostenlos starten →